Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,905,952,055
+$261,398,278 QoQ
Shares Held
11,548,053
-5.0% QoQ
Ownership
0.653%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#22
of 4,138 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $26,335,991,083 across 11 Drug Manufacturers - General names. ABBV ranks #4 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,145,229 | $6,171,342,532 | |
| 2 | JNJ |
Johnson & Johnson
|
19,286,904 | $4,898,295,007 | |
| 3 | AZN |
Astrazeneca PLC
|
25,750,245 | $4,882,761,455 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
11,548,053 | $2,905,952,055 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,873,343 | $2,425,224,575 | |
| 6 | AMGN |
Amgen Inc
|
3,816,942 | $1,382,191,036 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
10,421,131 | $1,316,605,688 | |
| 8 | PFE |
Pfizer Inc
|
43,233,122 | $1,041,053,576 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,905,952,055 | 11,548,053 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,644,553,777 | 12,159,427 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,772,344,799 | 12,133,331 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $2,779,425,608 | 12,004,084 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,136,609,450 | 11,510,664 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,447,597,554 | 11,681,928 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,058,585,729 | 11,584,613 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,374,564,094 | 12,024,327 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $2,033,032,905 | 11,853,037 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $2,221,961,983 | 12,201,878 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $1,903,550,748 | 12,283,350 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $1,802,811,237 | 12,094,534 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,701,314,392 | 12,627,584 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,894,359,951 | 11,886,553 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,896,988,683 | 11,738,065 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,646,899,767 | 12,271,066 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,919,149,937 | 12,530,360 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $1,954,090,636 | 12,054,103 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,525,911,557 | 11,269,657 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,255,906,894 | 11,642,782 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,259,208,415 | 11,179,052 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,188,898,750 | 10,985,943 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,208,688,429 | 11,280,340 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $948,463,321 | 10,828,443 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,094,529,488 | 11,148,192 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $715,665,468 | 9,393,168 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||